Versa HD>High-Tech Equipment>Hospital Introduction> Chungbuk National University Hospital

Versa HD

Versa HD

LocationB1 of the main building
PurchaseMay, 2016

Overview

Stereotactic treatments demand the highest levels of accuracy, precision and efficiency. As evidence continues to grow for new SRS and SBRT indications, ensure you have the right platform to empower the treatments of tomorrow.

Features

Enable high definition dynamic radiosurgery (HDRS)

Versa HD—our premium system—delivers absolute reliability, accuracy and confidence in stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT) treatments, to help you grow your stereotactic program as a mainstream technique. Confidently treat complex or challenging cancers with submillimeter, end-to-end accuracy.

“The use of Monaco, with the rapid and accurate Monte Carlo dose calculation algorithm, together with the high available modulation that can be achieved using Monaco and Agility allows highly accurate dose calculation, even for very small targets.”

Lip Tech Chew, PhD
Chief Medical Physicist
Farrer Park Hospital, Singapor

Provide stereotactic treatments with anatomically guided accuracy

The innovative imaging and motion management technology found in Versa HD gives clinicians the confidence to reduce margins and escalate dose to the target. It expands the scope of HDRS reaching smaller targets in locations previously untreatable with radiation.

“Versa HD will enable even more conformal treatments that should significantly limit normal tissue exposure and decrease side effects. We can deliver these state-of-the-art techniques with Versa HD and do it in such a way that it not only manages [the] cancer, but also minimizes the impact of treatment on [the patient's] quality of life.”

Douglas Einstein, MD, PhD, Chairman of Radiation
Oncology Kettering Medical Center, Kettering, Ohio,
USA

Assure end-to-end confidence

Our end-to-end Versa HD methodology provides the highest levels of dose delivery accuracy allowing you to push the boundaries of clinical capabilities.

“Advanced motion management technologies are critical to facilitate highly accurate and potent stereotactic radiation therapy for early stage inoperable lung tumors. Versa HD integrates these technologies and other solutions – such as 4D image guidance and sophisticated patient immobilization and treatment planning – into a specializes package for lung cancer. For the patient, it will mean a higher therapeutic dose of radiation to the lung tumor, with reduced exposure to nearby healthy tissues.”

Vivek Mehta, MD
, Director Center for Advanced
Targeted Radiotherapies, Swedish Cancer Institute,
Seattle, Washington USA